Next Science   Report issue

For profit Phase 4
Founded: Chatswood NSW Australia (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2014
NCT02138994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Next Science LLC | Next Science TM

Active Ingredients

Drugs in Phase 4 Trials (1)

benzalkonium (1 trial)

Drugs in Other Trials (3)

bacitracin (polysporin) (1 trial)

neomycin (1 trial)

polymyxin b sulfate (poly-rx) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Wound Infection (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4